Legend:
CC = Vancouver Convention Centre F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
416 !
|
Tue, 7/31/2018,
2:00 PM -
3:50 PM
|
CC-West 121
|
|
Clinical Trial Design- 4 — Contributed Papers
|
|
Biopharmaceutical Section
|
|
Chair(s): Lanju Zhang
|
|
2:05 PM
|
A Bayesian Framework for Calculating Predictive Probability of Success in Biomarker Development
Cong Li; Ling Wang, Takeda; Ray Liu, Takeda Pharmaceuticals Inc
|
|
2:20 PM
|
Dose Finding Model Selection in Oncology Combination Therapy
Lixia Pei, Janssen Pharmaceuticals ; Yichen Guo, Harvard University; Kevin Liu, Janssen Pharmaceuticals
|
|
2:35 PM
|
Testing Strategy in Phase 3 Trials with Multiple Doses
David Li, Pfizer; Simon Kirby, Pfizer
|
|
2:50 PM
|
ESTIMATION of SD for a LOG-TRANSFORMED VARIABLE BASED on SUMMARY STATISTICS in the ORIGINAL SCALE
Hui Quan, Sanofi; Juan Zhang, Sanofi; Deborah Dukovic, Sanofi; Dongli Zhou, Merck Senoro
|
|
3:05 PM
|
Analysis of Stratified Clinical Trials with Time-To-Event Endpoints
Devan V Mehrotra, Merck & Co., Inc.; Shanjun Helian, Merck & Co., Inc.; Shu-Chih Su, Merck Research Labs
|
|
3:20 PM
|
New Multiple Hypotheses Testing Procedures Based on Covering Principle
Hong Zhou, Arkansas State University; Huajiang Li, Avanir Pharmaceuticals
|
|
3:35 PM
|
Improving the Standards for Reporting of Clinical Trial Data
Jitendra Ganju, Consultant
|
|
